Fortis’s Agilus challenge deepens
Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
You may also like
Curefoods takes an old-school shot at a public listing
The Bengaluru-based startup has set its sights on an IPO all too quickly. A good mix of tech and services at a reasonable valuation might be its drawcard.
Out to list, Pine Labs is a hardware business pretending to be a fintech
Its core POS machine business is small and growing slowly, and the company has done little else to justify its high valuation.
Wakefit built a Rs 1,000-crore mattress brand. Now it wants to do a full-stack
A pioneer in the online D2C mattress market, the startup is eyeing the public markets on the strength of its expanded home and furnishings presence. Will its next decade be as good as the one behind it?
